Architectural Approach to the Management of the State Program of the «Digital Economy»

The purpose of the work is to build an architectural model of the digital economy, which combines the whole set of fundamental principles of its technological organization, which are embodied in a set of digital technologies, technology links with each other and with the external environment. The following tasks have been solved: — the properties and features of the digital economy are analyzed, — the preconditions for the architectural description of the digital economy are identified, — a stratified architectural model of the digital economy has been developed.It is shown that the architectural model of the digital economy should contain infrastructure and domain specific levels. The first group includes physical laws and technologies for building real and virtual sources of digital data, systems and networks for storing, distributing and processing data, as well as cloud, foggy and dew computations. The second group is the technology of creating data structures and analysis, building digital platforms and applications, creating an ecosystem digital platforms, digital markets and business process models.The basic methodology of the study uses the principles of designing system models developed in the construction of architectures of digital systems of Infocommunications, cloud computing, industrial Internet, big data, overlay services and other technologies of the third platform of informatization.The methodology used allowed us to divide the whole complex process of creating a digital economy into simpler parts — levels and sub-processes; to develop common concepts and terminology; to identify the basic functionality of technologies for all levels of the hierarchy; to form the basic competencies of specialists who study and implement different sub-processes; to simplify the task of organizing the interaction of products that implement sub-processes, etc

Extraction processing of concentrated solutions of uranyl nitrate with high impurities content

Process flowsheet of recycling uranium concentrated solutions with its purification from insoluble impurities of iron, silicon, molybdenum, calcium oxides and hydroxides and soluble impurities with application of centrifugal extractors cascade has been developed and suggested for commercial introduction. The process was carried out at extractant saturation (30 % tributyl phosphate in hydrocarbon diluent) in extraction assembly lower than a limiting level (85...95 g/l) and in wash assembly - at limiting saturation (up to 120 g/l). As a result the waste uranium content in water-tail solutions 0,01...0,04 g/l and minimal content of impurities in re-extractors is provide

Reaction-diffusion equations with spatially distributed hysteresis

The paper deals with reaction-diffusion equations involving a hysteretic discontinuity in the source term, which is defined at each spatial point. In particular, such problems describe chemical reactions and biological processes in which diffusive and nondiffusive substances interact according to hysteresis law. We find sufficient conditions that guarantee the existence and uniqueness of solutions as well as their continuous dependence on initial data.Comment: 30 pages, 14 figure

Towards a single-chip, implantable RFID system: is a single-cell radio possible?

We present an overview of progress towards single-chip RFID solutions. To date heterogeneous integration has been appropriate for non-biological systems. However, for in-vivo sensors and even drug delivery systems, a small form factor is required. We discuss fundamental limits on the size of the form factor, the effect of the antenna, and propose a unified single-chip RFID solution appropriate for a broad range of biomedical in-vivo device applications, both current and future. Fundamental issues regarding the possibility of single cell RF radios to interface with biological function are discussed

Health risk behaviours among adolescents in the English-speaking Caribbean: a review

<p>Abstract</p> <p>Background</p> <p>The aim of this paper was to review and summarize research on prevalence of health risk behaviours, their outcomes as well as risk and protective factors among adolescents in the English-speaking Caribbean.</p> <p>Methods</p> <p>Searching of online databases and the World Wide Web as well as hand searching of the <it>West Indian Medical Journal </it>were conducted. Papers on research done on adolescents aged 10 – 19 years old and published during the period 1980 – 2005 were included.</p> <p>Results</p> <p>Ninety-five relevant papers were located. Five papers were published in the 1980s, 47 in the 1990s, and from 2000–2005, 43 papers. Health risk behaviours and outcomes were divided into seven themes. Prevalence data obtained for these, included lifetime prevalence of <b>substance use</b>: cigarettes-24% and marijuana-17%; <b>high risk sexual behaviour</b>: initiation of sexual activity ≤ 10 years old-19% and those having more than six partners-19%; <b>teenage pregnancy</b>: teens account for 15–20% of all pregnancies and one-fifth of these teens were in their second pregnancy; <b>Sexually-Transmitted Infections (STIs)</b>: population prevalence of gonorrhoea and/or chlamydia in 18–21 year-olds was 26%; <b>mental health</b>: severe depression in the adolescent age group was 9%, and attempted suicide-12%; <b>violence and juvenile delinquency</b>: carrying a weapon to school in the last 30 days-10% and almost always wanting to kill or injure someone-5%; <b>eating disorders and obesity</b>: overweight-11%, and obesity-7%. Many of the risk behaviours in adolescents were shown to be related to the adolescent's family of origin, home environment and parent-child relationships. Also, the protective effects of family and school connectedness as well as increased religiosity noted in studies from the United States were also applicable in the Caribbean.</p> <p>Conclusion</p> <p>There is a substantial body of literature on Caribbean adolescents documenting prevalence and correlates of health risk behaviours. Future research should emphasize the designing and testing of interventions to alleviate this burden.</p

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Background Heterogeneity is a major obstacle to developing effective treatments for patients with primary Sjögren's syndrome. We aimed to develop a robust method for stratification, exploiting heterogeneity in patient-reported symptoms, and to relate these differences to pathobiology and therapeutic response. Methods We did hierarchical cluster analysis using five common symptoms associated with primary Sjögren's syndrome (pain, fatigue, dryness, anxiety, and depression), followed by multinomial logistic regression to identify subgroups in the UK Primary Sjögren's Syndrome Registry (UKPSSR). We assessed clinical and biological differences between these subgroups, including transcriptional differences in peripheral blood. Patients from two independent validation cohorts in Norway and France were used to confirm patient stratification. Data from two phase 3 clinical trials were similarly stratified to assess the differences between subgroups in treatment response to hydroxychloroquine and rituximab. Findings In the UKPSSR cohort (n=608), we identified four subgroups: Low symptom burden (LSB), high symptom burden (HSB), dryness dominant with fatigue (DDF), and pain dominant with fatigue (PDF). Significant differences in peripheral blood lymphocyte counts, anti-SSA and anti-SSB antibody positivity, as well as serum IgG, κ-free light chain, β2-microglobulin, and CXCL13 concentrations were observed between these subgroups, along with differentially expressed transcriptomic modules in peripheral blood. Similar findings were observed in the independent validation cohorts (n=396). Reanalysis of trial data stratifying patients into these subgroups suggested a treatment effect with hydroxychloroquine in the HSB subgroup and with rituximab in the DDF subgroup compared with placebo. Interpretation Stratification on the basis of patient-reported symptoms of patients with primary Sjögren's syndrome revealed distinct pathobiological endotypes with distinct responses to immunomodulatory treatments. Our data have important implications for clinical management, trial design, and therapeutic development. Similar stratification approaches might be useful for patients with other chronic immune-mediated diseases. Funding UK Medical Research Council, British Sjogren's Syndrome Association, French Ministry of Health, Arthritis Research UK, Foundation for Research in Rheumatology